Skip to main content
Top
Published in: Urolithiasis 4/2007

01-08-2007 | Original Paper

Oxalate synthesis from hydroxypyruvate in vitamin-B6-deficient rats

Authors: Yaovalak Teerajetgul, Rayhan Zubair Hossain, Kenichi Yamakawa, Makoto Morozumi, Kimio Sugaya, Yoshihide Ogawa

Published in: Urolithiasis | Issue 4/2007

Login to get access

Abstract

We studied the effects of an intravenous hydroxypyruvate load on endogenous oxalogenesis in rats receiving a standard diet or a vitamin-B6-deficient diet. Twelve male Wistar rats were randomized to two groups and were fed either a standard diet or a vitamin-B6-deficient diet for 3 weeks. Then the animals received an intravenous infusion of 100 mg/ml (960.6 μmol/ml) of hydroxypyruvate slowly over 10 min. Urine samples were collected just before hydroxypyruvate infusion and at hourly intervals until 5 h afterward. Urinary oxalate, glycolate, and citrate levels were measured by capillary electrophoresis. Hourly urinary oxalate excretion peaked within 2 h, while urinary glycolate excretion peaked at 1 h, after the hydroxypyruvate load in both control and vitamin-B6-deficient rats. Both urinary oxalate and glycolate excretion were higher in vitamin-B6-deficient rats than in control rats. Infusion of hydroxypyruvate increased the 5-h urinary oxalate and glycolate excretion to 0.68% (6.56 μmol) and 0.53% (5.10 μmol) of the administered dose (mol/mol), respectively, in the control rats, while oxalate and glycolate excretion, respectively, increased to 2.43% (23.36 μmol) and 0.79% (7.59 μmol) of the dose in the vitamin-B6-deficient rats. Urinary citrate excretion was significantly lower at baseline and all other times in the vitamin-B6-deficient rats than in the control rats. In conclusion, a hydroxypyruvate load increased endogenous oxalate synthesis in control rats, and its synthesis was even greater in vitamin-B6-deficient rats. Vitamin B6 deficiency also resulted in significant hypocitraturia.
Literature
1.
2.
go back to reference Ogawa Y, Yonou H, Hokama S, Oda M, Morozumi M, Sugaya K (2003) Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens. Front Biosci 8:a167–176PubMedCrossRef Ogawa Y, Yonou H, Hokama S, Oda M, Morozumi M, Sugaya K (2003) Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens. Front Biosci 8:a167–176PubMedCrossRef
3.
go back to reference Lewandowski S, Rodgers AL (2004) Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment. Clin Chim Acta 345:17–34PubMedCrossRef Lewandowski S, Rodgers AL (2004) Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment. Clin Chim Acta 345:17–34PubMedCrossRef
4.
go back to reference Holmes RP, Assimos DG (2004) The impact of dietary oxalate on kidney stone formation. Urol Res 32:311–316PubMedCrossRef Holmes RP, Assimos DG (2004) The impact of dietary oxalate on kidney stone formation. Urol Res 32:311–316PubMedCrossRef
5.
go back to reference Williams HE, Wanzilak TR (1989) Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol 141:742–749PubMed Williams HE, Wanzilak TR (1989) Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol 141:742–749PubMed
6.
go back to reference Holmes RP, Assimos DG (1998) Glyoxylate synthesis and its modulation and influence on oxalate synthesis. J Urol 160:1617–1624PubMedCrossRef Holmes RP, Assimos DG (1998) Glyoxylate synthesis and its modulation and influence on oxalate synthesis. J Urol 160:1617–1624PubMedCrossRef
7.
go back to reference Milliner D, Eickholt J, Bergstralh E, Wilson D, Smith L (1994) Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 331:1553–1558PubMedCrossRef Milliner D, Eickholt J, Bergstralh E, Wilson D, Smith L (1994) Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 331:1553–1558PubMedCrossRef
8.
go back to reference Kaelin A, Casez JP, Jaeger P (2004) Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria. Urol Res 32(1):61–68PubMedCrossRef Kaelin A, Casez JP, Jaeger P (2004) Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria. Urol Res 32(1):61–68PubMedCrossRef
9.
go back to reference Nishijima S, Sugaya K, Morozumi M, Hatano T, Ogawa Y (2003) Hepatic alanine-glyoxylate aminotransferase activity and oxalate metabolism in vitamin B6 deficient rats. J Urol 169(2):683–686PubMedCrossRef Nishijima S, Sugaya K, Morozumi M, Hatano T, Ogawa Y (2003) Hepatic alanine-glyoxylate aminotransferase activity and oxalate metabolism in vitamin B6 deficient rats. J Urol 169(2):683–686PubMedCrossRef
10.
go back to reference Runyan T, Gershoff SN (1965) The effect of vitamin B6 deficiency in rats on the metabolism of oxalic acid precursors. J Biol Chem 240:1889–1892PubMed Runyan T, Gershoff SN (1965) The effect of vitamin B6 deficiency in rats on the metabolism of oxalic acid precursors. J Biol Chem 240:1889–1892PubMed
11.
go back to reference Holmes RP (1995) Measurement of urinary oxalate and citrate by capillary electrophoresis and indirect ultraviolet absorbance. Clin Chem 41:1297–1301PubMed Holmes RP (1995) Measurement of urinary oxalate and citrate by capillary electrophoresis and indirect ultraviolet absorbance. Clin Chem 41:1297–1301PubMed
12.
go back to reference Ogawa Y, Hatano T (1997) Urinary oxalate and citrate determination. Kidney dialysis Suppl 43:151–157 Ogawa Y, Hatano T (1997) Urinary oxalate and citrate determination. Kidney dialysis Suppl 43:151–157
13.
go back to reference Ogawa Y, Hossain RZ, Ogawa T, Yamakawa K, Yonou H, Oshiro Y, Hokama S, Morozumi M, Uchida A, Sugaya K (2007) Vitamin B6 deficiency augments endogenous oxalogenesis after intravenous l-hydroxyproline loading in rats. Urol Res 35(1):15–21PubMedCrossRef Ogawa Y, Hossain RZ, Ogawa T, Yamakawa K, Yonou H, Oshiro Y, Hokama S, Morozumi M, Uchida A, Sugaya K (2007) Vitamin B6 deficiency augments endogenous oxalogenesis after intravenous l-hydroxyproline loading in rats. Urol Res 35(1):15–21PubMedCrossRef
14.
go back to reference Ogawa Y, Miyazato T, Hatano T (1999) Importance of oxalate precursors for oxalate metabolism in rats. J Am Soc Nephrol 10: S341–344PubMed Ogawa Y, Miyazato T, Hatano T (1999) Importance of oxalate precursors for oxalate metabolism in rats. J Am Soc Nephrol 10: S341–344PubMed
15.
go back to reference Pak CY (1994) Citrate and renal calculi: an update. Miner Electrolyte Metab 20:371–377PubMed Pak CY (1994) Citrate and renal calculi: an update. Miner Electrolyte Metab 20:371–377PubMed
16.
go back to reference Hallson PC, Rose GA, Sulaiman S (1983) Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine. Urol Int 28:179–181CrossRef Hallson PC, Rose GA, Sulaiman S (1983) Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine. Urol Int 28:179–181CrossRef
17.
go back to reference Nicar MJ, Hill K, Pak CYC (1987) Inhibition by citrate of spontaneous precipitation of calcium oxalate in vivo. J Bone Miner Res 2:215–220PubMed Nicar MJ, Hill K, Pak CYC (1987) Inhibition by citrate of spontaneous precipitation of calcium oxalate in vivo. J Bone Miner Res 2:215–220PubMed
18.
go back to reference Schwille PO, Schmiedl A, Hermann U, Fan J, Gottlieb D, Manoharan M, Wipplinger J (1999) Magnesium, citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis. Urol Res 27:117–126PubMedCrossRef Schwille PO, Schmiedl A, Hermann U, Fan J, Gottlieb D, Manoharan M, Wipplinger J (1999) Magnesium, citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis. Urol Res 27:117–126PubMedCrossRef
19.
go back to reference Ryall RL, Harnett RM, Marshall VR (1981) The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 112:349–356PubMedCrossRef Ryall RL, Harnett RM, Marshall VR (1981) The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 112:349–356PubMedCrossRef
20.
go back to reference Bek-Jensen H, Fornander AM, Nilsson MA, Tiselius HG (1996) Is citrate an inhibitor of calcium oxalate crystal growth in high concentration of urine? Urol Res 24:67–71PubMedCrossRef Bek-Jensen H, Fornander AM, Nilsson MA, Tiselius HG (1996) Is citrate an inhibitor of calcium oxalate crystal growth in high concentration of urine? Urol Res 24:67–71PubMedCrossRef
21.
go back to reference Tiselius HG, Fornander AM, Nilsson MA (1993) The effects of citrate and urine on calcium oxalate crystal aggregation. Urol Res 21:363–366PubMedCrossRef Tiselius HG, Fornander AM, Nilsson MA (1993) The effects of citrate and urine on calcium oxalate crystal aggregation. Urol Res 21:363–366PubMedCrossRef
22.
go back to reference Laube N, Jansen B, Hesse A (2002) Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones? Urol Res 30:336–341PubMedCrossRef Laube N, Jansen B, Hesse A (2002) Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones? Urol Res 30:336–341PubMedCrossRef
23.
go back to reference Murray RK, Granner DK, Mayes PA, Rodwell VW (1996) Chemical constituents of blood and body fluids. In: Harper’s Biochemistry, 24th edn. Appleton and Lange, Stamford, pp 829–34 Murray RK, Granner DK, Mayes PA, Rodwell VW (1996) Chemical constituents of blood and body fluids. In: Harper’s Biochemistry, 24th edn. Appleton and Lange, Stamford, pp 829–34
24.
go back to reference Ogawa Y, Yamaguchi K, Tanaka T, Morozumi M (1986) Effects of pyruvate salts, pyruvic acid, and bicarbonate salts in preventing experimental oxalate urolithiasis in rats. J Urol 135(5):1057–1060PubMed Ogawa Y, Yamaguchi K, Tanaka T, Morozumi M (1986) Effects of pyruvate salts, pyruvic acid, and bicarbonate salts in preventing experimental oxalate urolithiasis in rats. J Urol 135(5):1057–1060PubMed
25.
go back to reference Chow FH, Hamar DW, Boulay JP, Lewis LD (1978) Prevention of oxalate urolithiasis by some compounds. Invest Urol 15(6):493–495PubMed Chow FH, Hamar DW, Boulay JP, Lewis LD (1978) Prevention of oxalate urolithiasis by some compounds. Invest Urol 15(6):493–495PubMed
26.
go back to reference Scheid CR, Koul K, Hill WA et al (1996) Oxalate ion and calcium oxalate crystal interactions with renal epithelial cells. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stone: medial and surgical management. Lippincott-Raven, Philadelphia, pp 129–143 Scheid CR, Koul K, Hill WA et al (1996) Oxalate ion and calcium oxalate crystal interactions with renal epithelial cells. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stone: medial and surgical management. Lippincott-Raven, Philadelphia, pp 129–143
27.
go back to reference McKechnie R (1983) Oat products in bakery foods. Cereal Foods World 28(10):635–637 McKechnie R (1983) Oat products in bakery foods. Cereal Foods World 28(10):635–637
28.
go back to reference Leklem JE (1999) Vitamin B6. In: Shils ME, Olson JA, Shike M, Ross AC (eds) Modern nutrition in health and disease, 9th edn.. Williams Wilkins, Baltimore, pp 413–421 Leklem JE (1999) Vitamin B6. In: Shils ME, Olson JA, Shike M, Ross AC (eds) Modern nutrition in health and disease, 9th edn.. Williams Wilkins, Baltimore, pp 413–421
Metadata
Title
Oxalate synthesis from hydroxypyruvate in vitamin-B6-deficient rats
Authors
Yaovalak Teerajetgul
Rayhan Zubair Hossain
Kenichi Yamakawa
Makoto Morozumi
Kimio Sugaya
Yoshihide Ogawa
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 4/2007
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-007-0102-8

Other articles of this Issue 4/2007

Urolithiasis 4/2007 Go to the issue